Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

<p>ABSTRACT</p> <p>Background</p> <p>Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of para...

Full description

Bibliographic Details
Main Authors: Izquierdo María, Cavia Mónica, Muñiz Pilar, de Francisco Angel LM, Arias Manuel, Santos Javier, Abaigar Pedro
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Nephrology
Subjects:
Oxidative Stress
Immunomodulation
Receptors, Calcitriol
Paricalcitol
19-nor-1alpha,25-dihydroxyvitamin D2
Online Access:http://www.biomedcentral.com/1471-2369/13/159

Internet

http://www.biomedcentral.com/1471-2369/13/159

Similar Items